Literature DB >> 1982165

Increased cerebral blood flow in idiopathic pseudotumour cerebri.

C E Gross1, B I Tranmer, G Adey, J Kohut.   

Abstract

Cerebral blood flow was studied in nine patients with idiopathic pseudotumour and one patient with cortical vein thrombosis in Denver, Colorado using the 133Xe inhalation method. Globally elevated blood flows were found in all of the idiopathic pseudotumour patients averaging 149% of control values generated in the same setting. The patient with the cortical vein thrombosis demonstrated normal global flows. Possible pathophysiological mechanisms for these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1982165     DOI: 10.1080/01616412.1990.11739948

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  5 in total

1.  The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion.

Authors:  G A Bateman
Journal:  Neuroradiology       Date:  2003-01-16       Impact factor: 2.804

2.  Vascular hydraulics associated with idiopathic and secondary intracranial hypertension.

Authors:  Grant A Bateman
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

3.  Use of Phase-Contrast MRA to Assess Intracranial Venous Sinus Resistance to Drainage in Healthy Individuals.

Authors:  S Fall; G Pagé; J Bettoni; R Bouzerar; O Balédent
Journal:  AJNR Am J Neuroradiol       Date:  2016-12-08       Impact factor: 3.825

4.  A Possible Role for Temporary Lumbar Drainage in the Management of Idiopathic Intracranial Hypertension.

Authors:  Peter Gates; Peter McNeill
Journal:  Neuroophthalmology       Date:  2016-09-23

Review 5.  Changing concepts of cerebrospinal fluid hydrodynamics: role of phase-contrast magnetic resonance imaging and implications for cerebral microvascular disease.

Authors:  Stavros Michael Stivaros; Alan Jackson
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.